MYOV insider filings
Myovant Sciences Ltd. — 12 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-10. Screen MYOV transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for MYOV between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Myovant Sciences Ltd.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-10 | 4 | Valente Nancy — Director | Disposition to issuer (D): 3,673 · Disposition to issuer (D): 36,892 (derivative) | EDGAR |
| 2023-03-10 | 4 | Merendino Lauren — Chief Commercial Officer | Disposition to issuer (D): 21,791 · Disposition to issuer (D): 147,747 · Disposition to issuer (D): 123,300 (derivative) · Disposition to issuer (D): 103,703 (derivative) | EDGAR |
| 2023-03-10 | 4 | Mehra Uneek — Principal Financial Officer | Disposition to issuer (D): 20,724 · Disposition to issuer (D): 181,972 · Disposition to issuer (D): 165,192 (derivative) · Disposition to issuer (D): 111,111 (derivative) | EDGAR |
| 2023-03-10 | 4 | Lang Matthew — General Counsel & Corp. Secy. | Disposition to issuer (D): 113,145 · Disposition to issuer (D): 241,158 · Disposition to issuer (D): 220,000 (derivative) · Disposition to issuer (D): 87,050 (derivative) · Disposition to issuer (D): 152,110 (derivative) · Disposition to issuer (D): 170,396 (derivative) · +2 more | EDGAR |
| 2023-03-10 | 4 | Curran Terrie — Director | Disposition to issuer (D): 3,673 · Disposition to issuer (D): 33,846 (derivative) · Disposition to issuer (D): 11,154 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 5,250 (derivative) · +2 more | EDGAR |
| 2023-03-10 | 4 | Arjona Ferreira Juan Camilo — Chief Medical Officer | Disposition to issuer (D): 86,602 · Disposition to issuer (D): 160,082 · Disposition to issuer (D): 155,300 (derivative) · Disposition to issuer (D): 63,717 (derivative) · Disposition to issuer (D): 65,863 (derivative) · Disposition to issuer (D): 134,464 (derivative) · +2 more | EDGAR |
| 2023-03-10 | 4 | Gulfo Adele M. — Director | Disposition to issuer (D): 3,673 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 21,603 (derivative) · Disposition to issuer (D): 21,096 (derivative) | EDGAR |
| 2023-03-10 | 4 | Marek David C — Principal Executive Officer, Director | Disposition to issuer (D): 95,675 · Disposition to issuer (D): 321,924 · Disposition to issuer (D): 306,427 (derivative) · Disposition to issuer (D): 208,218 (derivative) · Disposition to issuer (D): 204,808 (derivative) · Disposition to issuer (D): 134,567 (derivative) | EDGAR |
| 2023-03-10 | 4 | GUINAN MARK — Director | Disposition to issuer (D): 3,673 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 58,608 (derivative) · Disposition to issuer (D): 21,603 (derivative) · Disposition to issuer (D): 21,096 (derivative) | EDGAR |
| 2023-03-10 | 4 | Sumitomo Chemical Co., Ltd. — 10% owner Sumitomo Pharma Co., Ltd. — 10% owner Sumitovant Biopharma Ltd. — 10% owner | Purchase (P): 51,599,200 @ $27 | EDGAR |
| 2023-03-10 | 4 | POTTER MYRTLE S — Director | Disposition to issuer (D): 3,673 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 58,608 (derivative) · Disposition to issuer (D): 21,603 (derivative) · Disposition to issuer (D): 21,096 (derivative) | EDGAR |
| 2023-03-06 | 4 | Sumitomo Chemical Co., Ltd. — 10% owner Sumitomo Pharma Co., Ltd. — 10% owner Sumitovant Biopharma Ltd. — 10% owner | Other (J): 4,243,005 @ $0 · Other (J): 1 (derivative) @ $0 | EDGAR |
Recent 8-K events — Myovant Sciences Ltd.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-10 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MYOV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →